Widespread use of oral glucose-electrolyte rehydration solutions (ORS) has resulted in a dramatic decrease in the morbidity and mortality associated with childhood gastroenteritis, regardless of its aetiology. Nevertheless, diarrhoeal disease remains the most common cause of death of children in developing countries, and current research efforts are directed towards optimising the efficacy of ORS, aiming for both simplicity and economy. Controversy regarding the 'ideal' sodium and glucose concentration continues to the extent that different formulations are now recommended in the developing and industrialised world. The inclusion of bicarbonate or a base precursor (citrate, acetate, or lactate) in ORS is generally assumed to be necessary, both for promotion of water and sodium absorption and correction of acidosis. This issue, however, has received little critical attention since the formal introduction of oral rehydration therapy. We have reviewed the available evidence from animal and human studies and conclude that there is little evidence to support the inclusion of bicarbonate or a base precursor in ORS. Although bicarbonate has similar effects on water and sodium absorption in the normal rat small intestine,t1 we have shown that bicarbonate and the base precursors acetate and citrate are unable (unlike glucose) to reverse water and sodium secretion induced by cholera toxin (Unpublished observations). These findings suggest that bicarbonate may not be beneficial with respect to the promotion of water absorption in the enterotoxin mediated diarrhoeas.
Role of base in the correction of metabolic acidosis
It is now generally accepted that in metabolic acidosis of childhood administration of bicarbonate should be reserved for conditions in which endogenous production or conservation of bicarbonate is inadequate to restore normal pH. Examples of such specific disorders include salicylism, prolonged diarrhoea, disorders of organic and amino acid metabolism, and renal tubular acidosis. In acute hypoxia and prerenal or circulatory failure bicarbonate is only recommended when pH fails to correct after restoration of adequate intravascular volume. Similarly, children with diabetes with ketoacidosis do not require bicarbonate providing adequate insulin and fluids are given and cardiovascular and renal function is normal, unless blood pH falls below 7-2.12
Metabolic acidosis during acute diarrhoea is generally attributed to bicarbonate loss in the stool, which results in loss of total blood buffering capacity. In addition, when dehydration is severe and renal plasma flow falls excretion of hydrogen ions and regeneration of bicarbonate is impaired. Also poor perfusion of peripheral tissue may contribute to a lactic acidosis. Acidosis is more likely to complicate cholera than other acute diarrhoea, as the stool concentration of bicarbonate is higher than in rotavirus or enterotoxigenic Escherichia coli diarrhoea and dehydration more pronounced (Table 2 ).13 14 Despite these theoretical considerations and the common finding of a reduced serum bicarbonate concentration in acute diarrhoea, mean arterial pH is often normal.
Thus, providing perfusion is maintained, renal compensation ensures that acid base state will normalise with rehydration without additional base in the vast majority of cases of acute gastroenteritis.
In severely dehydrated or acidotic patients Although several clinical studies suggest that citrate containing ORS may result in slightly lower stool volumes than equivalent bicarbonate containing ORS, the advantage of citrate over a solution without base has not been investigated.
It has been argued that the greater stability of lactate over citrate salts makes the former preferable for use in powdered ORS, but lactate containing solutions support mould growth, which may cause deterioration of glasswear and alter shelf life of the solution.2' Conclusions When considering ORSs, particularly for use in developing countries, our prime concerns must be simplicity, effectiveness, and economy. Bicarbonate and base precursors (acetate and citrate) pose problems with respect to availability, cost, packaging, and stability. Further, they are of dubious benefit therapeutically, both for correction of acidosis and rehydration. Exclusion of these substances would decrease the production cost of prepackaged ORS, make preparation in the home easier, and possibly result in earlier beginning of oral rehydra-tion therapy, leading ultimately to the prevention of serious dehydration.
MJGF is a Wellcome Trust Senior Lecturer and gratefully acknowledges financial support by the Wellcome Trust.
